Patent ID: 8415309
Filing Date: 2013-04-09
Classification: A61P,C07H

Abstract:
1. A pharmaceutical dosage form, comprising: a therapeutically effective amount of a compound selected from the group consisting of 4-amino-7-(2-C-methyl-β-D-ribofuranosyl)-pyrrolo[2,1-f][1,2,4]triazine; 4-amino-7-(2-C-methyl-β-D-ribofuranosyl)-pyrrolo[2,1-f][1,2,4]triazine 5′-monophosphate; 4-amino-7-(2-C-methyl-β-D-ribofuranosyl)-pyrrolo[2,1-f][1,2,4]triazine 5′-diphosphate; 4-amino-7-(2-C-methyl-β-D-ribofuranosyl)-pyrrolo[2,1-f][1,2,4]triazine 5′-triphosphate; and pharmaceutically acceptable salts thereof; and